ABUS Competitors & Alternatives
Compare Arbutus Biopharma Corp with similar stocks in the same industry
Biotechnology
ABUS
Main Stock$5.20
Tradestie Score
38
Market Cap
$879.90M
P/E Ratio
6.6
Revenue Growth
-0.9%
Analyst Upside
+6.6%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMTX
Immatics N.V. Ordinary Shares
|
$8.69
|
$1.09B | - | 39 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$11.46
|
$1.05B | 84.6 | 42 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.27
|
$1.01B | 108.3 | 56 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$5.35
|
$997.16M | - | 46 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.25
|
$996.55M | - | 45 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$106.65
|
$994.20M | - | 47 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$6.75
|
$993.46M | - | 34 | Compare |
|
IMNM
Immunome, Inc.
|
$28.01
|
$987.09M | - | 31 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$9.14
|
$952.74M | - | 44 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.78
|
$951.83M | - | 35 | Compare |
More ABUS Analysis
Data updated: Aug 25, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry